Abstract

Antigen recognition through the T cell receptor (TCR) αβ heterodimer is one of the primary determinants of the adaptive immune response. Vaccines activate naïve T cells with high specificity to expand and differentiate into memory T cells. However, antigen-specific memory CD4 T cells exist in unexposed antigen-naïve hosts. In this study, we use high-throughput sequencing of memory CD4 TCRβ repertoire and machine learning to show that individuals with preexisting vaccine-reactive memory CD4 T cell clonotypes elicited earlier and higher antibody titers and mounted a more robust CD4 T cell response to hepatitis B vaccine. In addition, integration of TCRβ sequence patterns into a hepatitis B epitope-specific annotation model can predict which individuals will have an early and more vigorous vaccine-elicited immunity. Thus, the presence of preexisting memory T cell clonotypes has a significant impact on immunity and can be used to predict immune responses to vaccination.

Data availability

The sequencing data that support the findings of this study have been deposited on Zenodo (https://doi.org/10.5281/zenodo.3989144).

The following data sets were generated

Article and author information

Author details

  1. George Elias

    Laboratory of Experimental Hematology (LEH), University of Antwerp, Antwerp, Belgium
    For correspondence
    igeorgeelias@gmail.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8419-9544
  2. Pieter Meysman

    Biomedical Informatics Research Network Antwerp, Department of Mathematics and Informatics, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5903-633X
  3. Esther Bartholomeus

    Department of Medical Genetics, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  4. Nicolas De Neuter

    Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6011-6457
  5. Nina Keersmaekers

    Centre for Health Economics Research & Modeling Infectious Diseases, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  6. Arvid Suls

    Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  7. Hilde Jansens

    Department of Clinical Microbiology, Antwerp University Hospital, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  8. Aisha Souquette

    Department of Immunology, St. Jude Children's Research Hospital, Memphis, United States
    Competing interests
    No competing interests declared.
  9. Hans De Reu

    Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  10. Marie-Paule Emonds

    Histocompatibility and Immunogenetic Laboratory, Rode Kruis-Vlaanderen, Mechelen, Belgium
    Competing interests
    No competing interests declared.
  11. Evelien Smits

    Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  12. Eva Lion

    Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  13. Paul G Thomas

    Department of Immunology, St. Jude Children's Research Hospital, Memphis, United States
    Competing interests
    No competing interests declared.
  14. Geert Mortier

    Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  15. Pierre Van Damme

    Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  16. Philippe Beutels

    Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  17. Kris Laukens

    Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
  18. Viggo Van Tendeloo

    Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    Competing interests
    Viggo Van Tendeloo, is an employee of Johnson & Johnson since 1/11/2019 and remains currently employed at the University of Antwerp.
  19. Benson Ogunjimi

    Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing, University of Antwerp, Antwerp, Belgium
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0831-2063

Funding

University of Antwerp

  • George Elias
  • Esther Bartholomeus
  • Nicolas De Neuter

Research Foundation Flanders

  • Pieter Meysman
  • Kris Laukens
  • Benson Ogunjimi

American Lebanese Syrian Associated Charities

  • Aisha Souquette
  • Paul G Thomas

National Institute of Allergy and Infectious Diseases

  • Aisha Souquette
  • Paul G Thomas

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Protocols involving the use of human tissues were approved by the Ethics Committee of Antwerp University Hospital and University of Antwerp (Antwerp, Belgium), and all of the experiments were performed in accordance with the protocols

Copyright

© 2022, Elias et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,202
    views
  • 323
    downloads
  • 16
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. George Elias
  2. Pieter Meysman
  3. Esther Bartholomeus
  4. Nicolas De Neuter
  5. Nina Keersmaekers
  6. Arvid Suls
  7. Hilde Jansens
  8. Aisha Souquette
  9. Hans De Reu
  10. Marie-Paule Emonds
  11. Evelien Smits
  12. Eva Lion
  13. Paul G Thomas
  14. Geert Mortier
  15. Pierre Van Damme
  16. Philippe Beutels
  17. Kris Laukens
  18. Viggo Van Tendeloo
  19. Benson Ogunjimi
(2022)
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination
eLife 11:e68388.
https://doi.org/10.7554/eLife.68388

Share this article

https://doi.org/10.7554/eLife.68388

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Xu Zheng, Shi Yu ... Guangxun Meng
    Research Article

    Innate immune responses triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection play pivotal roles in the pathogenesis of COVID-19, while host factors including proinflammatory cytokines are critical for viral containment. By utilizing quantitative and qualitative models, we discovered that soluble factors secreted by human monocytes potently inhibit SARS-CoV-2-induced cell-cell fusion in viral-infected cells. Through cytokine screening, we identified that interleukin-1β (IL-1β), a key mediator of inflammation, inhibits syncytia formation mediated by various SARS-CoV-2 strains. Mechanistically, IL-1β activates RhoA/ROCK signaling through a non-canonical IL-1 receptor-dependent pathway, which drives the enrichment of actin bundles at the cell-cell junctions, thus prevents syncytia formation. Notably, in vivo infection experiments in mice confirmed that IL-1β significantly restricted SARS-CoV-2 spread in the lung epithelium. Together, by revealing the function and underlying mechanism of IL-1β on SARS-CoV-2-induced cell-cell fusion, our study highlights an unprecedented antiviral function for cytokines during viral infection.

    1. Immunology and Inflammation
    Ning Song, Hang Gao ... Wenlong Zhang
    Research Article

    Gout is a prevalent form of inflammatory arthritis that occurs due to high levels of uric acid in the blood leading to the formation of urate crystals in and around the joints, particularly affecting the elderly. Recent research has provided evidence of distinct differences in the gut microbiota of patients with gout and hyperuricemia compared to healthy individuals. However, the link between gut microbiota and age-related gout remained underexplored. Our study found that gut microbiota plays a crucial role in determining susceptibility to age-related gout. Specifically, we observed that age-related gut microbiota regulated the activation of the NLRP3 inflammasome pathway and modulated uric acid metabolism. More scrutiny highlighted the positive impact of ‘younger’ microbiota on the gut microbiota structure of old or aged mice, enhancing butanoate metabolism and butyric acid content. Experimentation with butyrate supplementation indicated that butyric acid exerts a dual effect, inhibiting inflammation in acute gout and reducing serum uric acid levels. These insights emphasize the potential of gut microbiome rejuvenation in mitigating senile gout, unraveling the intricate dynamics between microbiota, aging, and gout. It potentially serves as a therapeutic target for senile gout-related conditions.